Specialized Working Group on Precision Hematology

Overview

The Precision Hematology SWG is advancing progress by driving the implementation of precision hematology at multiple levels. 

Our aim is to increase precision to a level where personalized therapies for every patient is possible. This will enable the best possible care for malignant hematology patients based on the unique characteristics of their cancer.   

We’re currently focused on: 

• Applying new technologies that improve functional classification of cancer based on biology 
• Innovating in clinical trial design 
• Working to change the regulatory landscape to provide the necessary flexibility  

Our goals

1. Foster research in precision hematology

• Promote scientific exchange and education. 
• Develop frameworks to enable translational research—e.g. standardized data and sample collections. 
• Joint funding applications. 

2. Foster the development of diagnostic tests, platforms and technologies that enable therapy matching  

• Scientific exchange and education. 
• Developing frameworks and reporting standards of results across molecular and functional platforms. 

3. Foster clinical trials that evaluate these tests in their capabilities to improve patient care

• Scientific exchange. 
• Developing concepts of Precision Medicine (PM) trial design.  
• Lobby for public funding of PM trials. 

4. Foster access to drugs upon molecular or functional test results

• Outline and develop the legal and ethical requirement for histology-agnostic therapy matching. 
• Engage with stakeholders (patients, doctors, public, industry). 

Join us

If you work in our field and share our mission to advance progress through precision hematology, you’d be welcome to join our SWG. However, before you apply, we recommend you read our application guidance.

Ready? Apply now on the EHA Portal.

If you have any questions, please email our SWGs team.